A New Dawn for Families: UK’s First Babies Born Free of Hereditary Disease Using Three-Person DNA

In a groundbreaking medical achievement, eight babies have been born in the UK free from incurable mitochondrial disease, thanks to a pioneering fertility technique using DNA from three people. The…

Continue Reading A New Dawn for Families: UK’s First Babies Born Free of Hereditary Disease Using Three-Person DNA

Takeda’s Oveporexton: A Promising Step

Takeda Pharmaceuticals has announced positive results from a pivotal Phase 3 trial of oveporexton, a novel therapy targeting orexin deficiency in patients with narcolepsy. According to BioPharmaDive.com, this development marks…

Continue Reading Takeda’s Oveporexton: A Promising Step

Brogidirsen and the Promise of Exon 44 Skipping: New Horizons in RNA Therapy for Duchenne Muscular Dystrophy

Duchenne muscular dystrophy (DMD) is a devastating, inherited muscle-wasting disorder caused by mutations in the DMD gene, leading to an absence of functional dystrophin protein. While current standards of care,…

Continue Reading Brogidirsen and the Promise of Exon 44 Skipping: New Horizons in RNA Therapy for Duchenne Muscular Dystrophy

A Potential Turning Point: CAR T-Cell Therapy Shows Long-Term Survival in Advanced Multiple Myeloma

At the recent American Society of Clinical Oncology (ASCO) annual meeting, researchers unveiled remarkable long-term results for ciltacabtagene autoleucel (cilta-cel; Carvykti), a CAR T-cell therapy, in patients with heavily pretreated…

Continue Reading A Potential Turning Point: CAR T-Cell Therapy Shows Long-Term Survival in Advanced Multiple Myeloma

Real-World Outcomes of Ataluren in Duchenne Muscular Dystrophy: Evidence from the STRIDE Registry

Duchenne Muscular Dystrophy (DMD) is a severe, progressive neuromuscular disease that primarily affects boys, leading to muscle weakness, loss of ambulation, and premature death. Among therapeutic advances, ataluren has emerged…

Continue Reading Real-World Outcomes of Ataluren in Duchenne Muscular Dystrophy: Evidence from the STRIDE Registry

Achieving Global Excellence in Duchenne Muscular Dystrophy Care: The Accredited Duchenne Centers Program

The Accredited Duchenne Centers (ADC) Program, spearheaded by the World Duchenne Organization (WDO), is a pioneering global initiative designed to standardize and elevate care for individuals living with Duchenne Muscular…

Continue Reading Achieving Global Excellence in Duchenne Muscular Dystrophy Care: The Accredited Duchenne Centers Program